Achillion Announces Upcoming Presentation of Interim Phase 2a Results
According to Achillion Pharmaceuticals, it is estimated that over 150 million people around the world are infected with the hepatitis C virus (HCV). Most people infected with HCV go undiagnosed and it has become a major global health threat. In light of this, I was pleased to hear about the announcement Achillion Pharmaceuticals made last week. Achillion announced that interim results from their phase 2a clinical trial were accepted for presentation at the EASL — American As
